FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800635729> ?p ?o ?g. }

• W2800635729 endingPage "1382" @default.
• W2800635729 startingPage "1376" @default.
• W2800635729 abstract "OBJECTIVE The Pipeline embolization device (PED) has become a valuable tool in the treatment of cerebral aneurysms. Although failures with PED treatment have been reported, the characteristics and course of these aneurysms remain a topic of uncertainty. METHODS Electronic medical records and imaging studies were reviewed for all patients treated with the PED between July 2010 and March 2015 to identify characteristics of patients and aneurysms with residual filling after PED treatment. RESULTS Of 316 cases treated at a single institution, 281 patients had a long-term follow-up. A total of 52 (16.4%) aneurysms with residual filling were identified and constituted the study population. The mean patient age in this population was 58.8 years. The mean aneurysm size was 10.1 mm ± 7.15 mm. Twelve aneurysms were fusiform (23%). Of the aneurysms with residual filling, there were 20 carotid ophthalmic (CO) aneurysms (20% of all CO aneurysms treated), 10 other paraclinoid aneurysms (16.4% of all paraclinoid aneurysms), 7 posterior communicating artery (PCoA) aneurysms (21.9% of all PCoA aneurysms), 7 cavernous internal carotid artery (ICA) aneurysms (14.9% of all cavernous ICA aneurysms), 4 vertebrobasilar (VB) junction aneurysms (14.8% of all VB junction aneurysms), and 3 middle cerebral artery (MCA) aneurysms (25% of all MCA aneurysms). Eleven patients underwent placement of more than one PED (21.2%), with a mean number of devices of 1.28 per case. Eight of 12 aneurysms were previously treated with a stent (15.4%). Nineteen patients underwent re-treatment (36.5%); the 33 patients who did not undergo re-treatment (63.5%) were monitored by angiography or noninvasive imaging. In multivariate analysis, age older than 65 years (OR 2.65, 95% CI 1.33–5.28; p = 0.05), prior stent placement across the target aneurysm (OR 2.94, 95% CI 1.15–7.51; p = 0.02), aneurysm location in the distal anterior circulation (MCA, PCoA, and anterior choroidal artery: OR 2.72, 95% CI 1.19–6.18; p = 0.017), and longer follow-up duration (OR 1.06, 95% CI 1.03–1.09; p < 0.001) were associated with incomplete aneurysm occlusion. CONCLUSIONS While the PED can allow for treatment of large, broad-necked aneurysms with high efficacy, treatment failures do occur (16.4%). Aneurysm size, shape, and previous treatment may influence treatment outcome." @default.
• W2800635729 created "2018-05-17" @default.
• W2800635729 creator A5007946587 @default.
• W2800635729 creator A5027642854 @default.
• W2800635729 creator A5030396271 @default.
• W2800635729 creator A5051627945 @default.
• W2800635729 creator A5053752894 @default.
• W2800635729 creator A5054050011 @default.
• W2800635729 creator A5061484429 @default.
• W2800635729 creator A5072023956 @default.
• W2800635729 creator A5088798682 @default.
• W2800635729 date "2019-04-01" @default.
• W2800635729 modified "2023-10-11" @default.
• W2800635729 title "Aneurysms with persistent filling after failed treatment with the Pipeline embolization device" @default.
• W2800635729 cites W1771942405 @default.
• W2800635729 cites W1892522507 @default.
• W2800635729 cites W1968815368 @default.
• W2800635729 cites W1985646892 @default.
• W2800635729 cites W1995395749 @default.
• W2800635729 cites W2011222541 @default.
• W2800635729 cites W2013601239 @default.
• W2800635729 cites W2027976562 @default.
• W2800635729 cites W2045423900 @default.
• W2800635729 cites W2059470142 @default.
• W2800635729 cites W2073196582 @default.
• W2800635729 cites W2082022147 @default.
• W2800635729 cites W2083461513 @default.
• W2800635729 cites W2098411913 @default.
• W2800635729 cites W2109727288 @default.
• W2800635729 cites W2124360594 @default.
• W2800635729 cites W2132276423 @default.
• W2800635729 cites W2153528438 @default.
• W2800635729 cites W2159182634 @default.
• W2800635729 cites W2166587773 @default.
• W2800635729 cites W2198526197 @default.
• W2800635729 cites W2249050550 @default.
• W2800635729 cites W2276833623 @default.
• W2800635729 cites W2279578850 @default.
• W2800635729 cites W2290554350 @default.
• W2800635729 cites W2316134095 @default.
• W2800635729 cites W2345744740 @default.
• W2800635729 cites W2515355621 @default.
• W2800635729 doi "https://doi.org/10.3171/2017.12.jns163090" @default.
• W2800635729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29726765" @default.
• W2800635729 hasPublicationYear "2019" @default.
• W2800635729 type Work @default.
• W2800635729 sameAs 2800635729 @default.
• W2800635729 citedByCount "18" @default.
• W2800635729 countsByYear W28006357292018 @default.
• W2800635729 countsByYear W28006357292019 @default.
• W2800635729 countsByYear W28006357292020 @default.
• W2800635729 countsByYear W28006357292021 @default.
• W2800635729 countsByYear W28006357292022 @default.
• W2800635729 countsByYear W28006357292023 @default.
• W2800635729 crossrefType "journal-article" @default.
• W2800635729 hasAuthorship W2800635729A5007946587 @default.
• W2800635729 hasAuthorship W2800635729A5027642854 @default.
• W2800635729 hasAuthorship W2800635729A5030396271 @default.
• W2800635729 hasAuthorship W2800635729A5051627945 @default.
• W2800635729 hasAuthorship W2800635729A5053752894 @default.
• W2800635729 hasAuthorship W2800635729A5054050011 @default.
• W2800635729 hasAuthorship W2800635729A5061484429 @default.
• W2800635729 hasAuthorship W2800635729A5072023956 @default.
• W2800635729 hasAuthorship W2800635729A5088798682 @default.
• W2800635729 hasBestOaLocation W28006357291 @default.
• W2800635729 hasConcept C126838900 @default.
• W2800635729 hasConcept C141071460 @default.
• W2800635729 hasConcept C164705383 @default.
• W2800635729 hasConcept C2775841333 @default.
• W2800635729 hasConcept C2776035437 @default.
• W2800635729 hasConcept C2776098176 @default.
• W2800635729 hasConcept C2776674566 @default.
• W2800635729 hasConcept C2778333808 @default.
• W2800635729 hasConcept C2778583881 @default.
• W2800635729 hasConcept C2780540156 @default.
• W2800635729 hasConcept C2781012200 @default.
• W2800635729 hasConcept C2909310872 @default.
• W2800635729 hasConcept C541997718 @default.
• W2800635729 hasConcept C71924100 @default.
• W2800635729 hasConceptScore W2800635729C126838900 @default.
• W2800635729 hasConceptScore W2800635729C141071460 @default.
• W2800635729 hasConceptScore W2800635729C164705383 @default.
• W2800635729 hasConceptScore W2800635729C2775841333 @default.
• W2800635729 hasConceptScore W2800635729C2776035437 @default.
• W2800635729 hasConceptScore W2800635729C2776098176 @default.
• W2800635729 hasConceptScore W2800635729C2776674566 @default.
• W2800635729 hasConceptScore W2800635729C2778333808 @default.
• W2800635729 hasConceptScore W2800635729C2778583881 @default.
• W2800635729 hasConceptScore W2800635729C2780540156 @default.
• W2800635729 hasConceptScore W2800635729C2781012200 @default.
• W2800635729 hasConceptScore W2800635729C2909310872 @default.
• W2800635729 hasConceptScore W2800635729C541997718 @default.
• W2800635729 hasConceptScore W2800635729C71924100 @default.
• W2800635729 hasIssue "4" @default.
• W2800635729 hasLocation W28006357291 @default.
• W2800635729 hasLocation W28006357292 @default.
• W2800635729 hasOpenAccess W2800635729 @default.
• W2800635729 hasPrimaryLocation W28006357291 @default.

• next